X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5811) 5811
Publication (545) 545
Book / eBook (83) 83
Book Review (83) 83
Book Chapter (18) 18
Magazine Article (18) 18
Dissertation (2) 2
Conference Proceeding (1) 1
Newspaper Article (1) 1
Streaming Video (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4164) 4164
peripheral nervous system diseases - chemically induced (3921) 3921
male (3066) 3066
female (2367) 2367
animals (2116) 2116
index medicus (1782) 1782
middle aged (1716) 1716
adult (1641) 1641
rats (1254) 1254
aged (1140) 1140
neurosciences (809) 809
peripheral neuropathy (756) 756
oncology (754) 754
chemotherapy (708) 708
antineoplastic agents - adverse effects (669) 669
peripheral vascular disease (638) 638
peripheral nervous system diseases - physiopathology (607) 607
clinical neurology (582) 582
peripheral nervous system diseases - pathology (581) 581
cancer (544) 544
neurotoxicity (537) 537
neuropathy (529) 529
disease models, animal (474) 474
rats, sprague-dawley (456) 456
mice (452) 452
time factors (432) 432
pharmacology & pharmacy (410) 410
dose-response relationship, drug (384) 384
peripheral nervous system diseases - diagnosis (374) 374
treatment outcome (364) 364
adolescent (359) 359
risk factors (356) 356
pain (345) 345
peripheral nervous system diseases - drug therapy (335) 335
paclitaxel (318) 318
antineoplastic combined chemotherapy protocols - adverse effects (305) 305
antineoplastic combined chemotherapy protocols - therapeutic use (303) 303
nervous system diseases - chemically induced (303) 303
research (296) 296
care and treatment (292) 292
article (283) 283
therapy (279) 279
neural conduction - drug effects (277) 277
peripheral nervous system diseases - prevention & control (275) 275
paclitaxel - adverse effects (259) 259
physiology (256) 256
analysis (247) 247
research article (247) 247
aged, 80 and over (245) 245
health aspects (244) 244
occupational diseases - chemically induced (244) 244
neoplasms - drug therapy (242) 242
hypertension - chemically induced (235) 235
hematology (232) 232
toxicity (232) 232
nervous system (230) 230
toxicology (226) 226
cardiac & cardiovascular systems (213) 213
rats, wistar (212) 212
cisplatin (210) 210
oxaliplatin (210) 210
electromyography (207) 207
medicine & public health (203) 203
blood pressure - drug effects (202) 202
drug administration schedule (202) 202
medicine, general & internal (200) 200
neuropathic pain (197) 197
neural conduction (195) 195
organoplatinum compounds - adverse effects (192) 192
cisplatin - adverse effects (190) 190
antineoplastic agents - therapeutic use (189) 189
neurons (187) 187
rat (187) 187
peripheral nervous system diseases - metabolism (184) 184
bortezomib (183) 183
child (182) 182
neurology (182) 182
peripheral nervous system diseases - epidemiology (181) 181
prospective studies (181) 181
hypertension - physiopathology (180) 180
retrospective studies (177) 177
peripheral nerves - drug effects (171) 171
peripheral nerves - pathology (168) 168
breast neoplasms - drug therapy (166) 166
antineoplastic agents, phytogenic - adverse effects (164) 164
medicine (164) 164
complications and side effects (163) 163
peripheral nervous system diseases - etiology (160) 160
inflammation (158) 158
induced peripheral neuropathy (155) 155
multiple myeloma - drug therapy (155) 155
physiological aspects (155) 155
hyperalgesia - chemically induced (154) 154
hypertension (154) 154
follow-up studies (152) 152
electrophysiology (151) 151
pain - chemically induced (151) 151
vincristine - adverse effects (151) 151
drug therapy (150) 150
oxidative stress (150) 150
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (70) 70
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Online Resources - Online (1) 1
Providence Healthcare - Stacks (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
St. Michael's Hospital - Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
West Park Healthcare Centre - Hospital Department (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5314) 5314
French (150) 150
Japanese (145) 145
German (93) 93
Spanish (52) 52
Italian (50) 50
Chinese (31) 31
Russian (29) 29
Polish (17) 17
Portuguese (9) 9
Dutch (8) 8
Norwegian (8) 8
Danish (6) 6
Hebrew (6) 6
Czech (3) 3
Swedish (3) 3
Serbian (2) 2
Bulgarian (1) 1
Hungarian (1) 1
Romanian (1) 1
Romansh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CA: A Cancer Journal for Clinicians, ISSN 0007-9235, 07/2013, Volume 63, Issue 4, pp. 249 - 279
Answer questions and earn CME/CNE Advances in genomics and molecular biology have identified aberrant proteins in cancer cells that are attractive targets for... 
toxicity | kinase inhibitors | therapeutic index | targeted agents | mechanism‐based toxicity | immunotherapeutic agents | off‐target toxicity | mechanism-based toxicity | off-target toxicity | MEK INHIBITOR TRAMETINIB | PULMONARY ARTERIAL-HYPERTENSION | I DOSE-ESCALATION | CHRONIC MYELOID-LEUKEMIA | GROWTH-FACTOR RECEPTOR | ONCOLOGY | PLACEBO-CONTROLLED TRIAL | III CLINICAL-TRIAL | SQUAMOUS-CELL CARCINOMAS | TIVANTINIB ARQ 197 | SIGNAL-REGULATED KINASE | Mood Disorders - chemically induced | Drug Eruptions - etiology | Peripheral Nervous System Diseases - chemically induced | Bone Marrow Diseases - chemically induced | Cachexia - chemically induced | Endocrine System Diseases - chemically induced | Pleural Effusion - chemically induced | Humans | Drug Eruptions - therapy | Immune System Diseases - chemically induced | Lung Diseases, Interstitial - chemically induced | Thrombocytopenia - chemically induced | Diarrhea - chemically induced | Neoplasms - drug therapy | Antineoplastic Agents - adverse effects | Exanthema - chemically induced | Hyperbilirubinemia - chemically induced | Venous Thromboembolism - chemically induced | Vision Disorders - chemically induced | Hemorrhage - chemically induced | Heart Diseases - chemically induced | Hyperlipidemias - chemically induced | Magnesium - blood | Antimitotic agents | Drugs | Prevention | Complications and side effects | Drug targeting | Antineoplastic agents | Health aspects | Risk factors | Proteins | Side effects | Genomics | Cytotoxicity | Molecular biology | Cancer therapies | Cells | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2012, Volume 30, Issue 21, pp. 2691 - 2697
Monoclonal antibodies directed against the immune checkpoint protein cytotoxic T-lymphocyte antigen-4 (CTLA-4; CD152)-ipilimumab and tremelimumab-have been... 
REGRESSION | METASTATIC MELANOMA | LYMPHOCYTE-ASSOCIATED ANTIGEN-4 | EFFICACY | ONCOLOGY | PHASE-II | MONOCLONAL-ANTIBODY | CTLA-4 | PATIENT | CANCER-IMMUNOTHERAPY | BLOCKADE | Stevens-Johnson Syndrome - immunology | Peripheral Nervous System Diseases - chemically induced | Skin Neoplasms - drug therapy | Humans | Ipilimumab | Antibodies, Monoclonal - adverse effects | Scleritis - chemically induced | Antineoplastic Agents - administration & dosage | Liver - immunology | Liver - drug effects | Antineoplastic Agents - adverse effects | Diarrhea - immunology | Pancreatitis - immunology | Scleritis - immunology | Mucous Membrane - drug effects | Colitis - immunology | Peripheral Nervous System Diseases - immunology | Antibodies, Monoclonal - immunology | Drug Eruptions - immunology | Skin - immunology | Melanoma - metabolism | Skin Neoplasms - pathology | Skin Neoplasms - immunology | Antineoplastic Agents - immunology | CTLA-4 Antigen - drug effects | Lymphatic Diseases - immunology | Antibodies, Monoclonal - pharmacokinetics | CTLA-4 Antigen - immunology | Pancreatitis - chemically induced | Melanoma - secondary | Chemical and Drug Induced Liver Injury - immunology | Pituitary Gland - immunology | Skin Neoplasms - metabolism | Lymphatic Diseases - chemically induced | Mucous Membrane - immunology | Antibodies, Monoclonal - administration & dosage | Melanoma - immunology | Uveitis - immunology | Melanoma - drug therapy | Uveitis - chemically induced | Pituitary Gland - drug effects | Skin - drug effects | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2014, Volume 32, Issue 18, pp. 1941 - 1967
Purpose To provide evidence-based guidance on the optimum prevention and treatment approaches in the management of chemotherapy-induced peripheral neuropathies... 
ACUTE PAIN SYNDROME | PROSPECTIVE SURVEILLANCE MODEL | ONCOLOGY | DOUBLE-BLIND | REDUCED GLUTATHIONE | QUALITY-OF-LIFE | CISPLATIN-INDUCED TOXICITIES | VITAMIN-E SUPPLEMENTATION | PLACEBO-CONTROLLED TRIAL | OXALIPLATIN-RELATED NEUROTOXICITY | ADVANCED COLORECTAL-CANCER | Thiophenes - therapeutic use | Peripheral Nervous System Diseases - chemically induced | United States | Humans | Peripheral Nervous System Diseases - physiopathology | Antineoplastic Agents - administration & dosage | Ketamine - administration & dosage | Incidence | Neuralgia - prevention & control | Peripheral Nervous System Diseases - prevention & control | Antineoplastic Agents - adverse effects | Amines - therapeutic use | Neuralgia - etiology | Adult | gamma-Aminobutyric Acid - therapeutic use | Drug Therapy, Combination | Peripheral Nervous System Diseases - complications | Severity of Illness Index | Analgesics - therapeutic use | Cyclohexanecarboxylic Acids - therapeutic use | Gels | Baclofen - administration & dosage | Comorbidity | Survivors | Anticonvulsants - therapeutic use | Treatment Outcome | Evidence-Based Medicine | Neuralgia - drug therapy | Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Antidepressive Agents, Tricyclic - therapeutic use | Duloxetine Hydrochloride | Quality of Life | Peripheral Nervous System Diseases - drug therapy | Amitriptyline - administration & dosage
Journal Article
JAMA, ISSN 0098-7484, 04/2013, Volume 309, Issue 13, pp. 1359 - 1367
Journal Article
Neuroscience Letters, ISSN 0304-3940, 06/2015, Volume 596, pp. 90 - 107
Journal Article